ESC Heart Failure

Article	Citations
Use of Sodium Glucose Co-Transporter 2 Inhibitors in Acute Heart Failure: A Practical Guidance	185
Global Differences in Acute Heart Failure Treatment: Analysis of the STRONG-HF Site Feasibility Questionnaire	109
Serum Angiotensin-Converting Enzyme Levels Indicating Early Sarcoidosis Diagnosis and Immunosuppressive Therapy Efficacy	89
Establishing a Novel Model to Assess Exercise Capacity in Chronic Heart Failure Based on Stress Echocardiography	77
	60
Explainable Machine Learning and Online Calculators to Predict Heart Failure Mortality in Intensive Care Units	60
	58
Editors’ Highlight Picks from 2023 in ESC Heart Failure	57
Outcomes with Sacubitril/Valsartan in Outpatients with Heart Failure and Reduced Ejection Fraction: The ARIADNE Registry	55
Impact of Age on Characteristics, Performance Measures and Outcomes of Inpatients for Heart Failure in Beijing, China	52
New insight: Particle Flow Rate from the Airways as an Indicator of Cardiac Failure in the Intensive Care Unit	51
Blood Perfusion Status is Important in the Prognosis of Ventricular Aneurysm Complicated by Ventricular Septal Rupture	50
Issue Information	49
The Use of MitraClip for Nonobstructive Hypertrophic Cardiomyopathy with Mixed Severe Mitral Valve Regurgitation	48
Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI	48
Cardiovascular risk associated with polypharmacy in heart failure: a systematic review and meta-analysis	48
Prognostic Value of Hypoxaemic Burden from Overnight Oximetry in Heart Failure with Preserved Ejection Fraction	47
Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity	47
Clinical Course of Patients with Hypertrophic Cardiomyopathy Away from Tertiary Referral Care	44
The adjusted ferritin inflammation index: a novel metric for predicting mortality in heart failure with reduced and mildly reduced ejection fraction	44
Percutaneous Endocardial Alginate–Hydrogel Injection in the Treatment of Heart Failure: First-in-Human Study	40
Atrial Fibrillation Ablation in Patients with Arrhythmia-Induced Cardiomyopathy: A Prospective Multicentre Study	40
Arterio-venous gradient of active interleukin-18 is associated with diastolic dysfunction: a cross-sectional study	39
Predictors of stroke volume improvement with AV-optimized conduction system pacing in patients with AV dromotropathy	39
Risk Classification for Long-Term Mortality Among Patients with Acute Heart Failure: China PEACE 4YMortality	39

Elevated Activin-A serum levels in patients with acute peripartum cardiomyopathy and during left ventricular recovery	37
Calcium Channel Blockers and Clinical Outcomes in Patients with Continuous-Flow Left Ventricular Assist Devices	37
Vasopressin in cardiogenic shock: pathophysiology, clinical evidence, and therapeutic perspectives	36
Sex Differences in the Impact of Frailty on Patients with Heart Failure: A Retrospective Cohort Study	36
Early Achievement of Walkability After Cardiac Surgery and the Risk of Cardiovascular Disease After Hospital Discharge	36
Integrated Care for Older Multimorbid Heart Failure Patients: Protocol for the ESCAPE Randomized Trial and Cohort Study	36
Biomarker Profiles in Heart Failure with Preserved vs. Reduced Ejection Fraction: Results from the DIAST-CHF Study	35
Increased Acylcarnitines in Infant Heart Failure Indicate Fatty Acid Oxidation Inhibition: Towards Therapeutic Options?	35
Meta-Analysis Global Group in Chronic Heart Failure Score for the Prediction of Mortality in Valvular Heart Disease	35
Heart Failure and Trimethylamine N-Oxide: Time to Transform a ‘Gut Feeling’ in a Fact?	35
Closing the gap between trial and clinical reality in long-term left ventricular assist device use outcomes	35
Intense Optimization of Oral Therapy Rapidly Restores Respiratory Function in Worsening Heart Failure Patients	34
Effect of Beta-Blockade on Mortality in Patients with Cardiac Amyloidosis: A Systematic Review and Meta-Analysis	34
Long-Term Outcomes of Electrical Storm Patients Listed for Urgent Heart Transplantation but not Transplanted Acutely	34
Prevalence of Transthyretin Amyloidosis Among Heart Failure Patients with Preserved Ejection Fraction in Japan	33
Meta-Analysis of Cardiac Magnetic Resonance in Prognosticating Left Ventricular Function in Peripartum Cardiomyopathy	32
Impact of Early Intensive GDMT on LVEF Recovery and ICD Decision Making in de Novo HFrEF	32
Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction	31
Prognostic Value of Left Atrial Strain in Acute and Chronic Heart Failure: A Meta-Analysis	31
Analysis of the Serum Levels of RIP3 and Drp1 in Patients with Heart Failure	31
Reductions in Renin-Angiotensin System Inhibitors Following Hospitalization for Heart Failure	30
The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank study	29
Fibroblast Growth Factor 23 Independently Predicts Adverse Outcomes After an Acute Coronary Syndrome	29
Assessing the Link of Malnutrition with Diabetes and Mortality Risk in Heart Failure Patients	29
Characteristics and Management of Very Elderly Patients with Heart Failure: A Retrospective, Population Cohort Study	29
Acylation-Stimulating Protein and Heart Failure Progression in Arrhythmogenic Right Ventricular Cardiomyopathy	28
Cardiac remodelling and functional status after cardiac resynchronization therapy: comparison between de-novo implantation and upgrade from right ventricular pacing	28
Real-Time Pulmonary Artery Pressure Monitoring in Heart Failure Patients: An Updated Cost-Effectiveness Analysis	28
Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis	28
Predictive Value of Global Longitudinal Strain by Left Ventricular Ejection Fraction	27
Predicting Cardiovascular Events with Fluoropyrimidine Chemotherapy Using a Standard Cardiovascular Risk Calculator	27
Health-Related Quality of Life Among Transthyretin Amyloid Cardiomyopathy Patients	27
Cardiogenic Shock Requiring VA-ECMO Therapy in Scorpionism-Induced Myocarditis	27
Platelet Count in Heart Failure Patients Undergoing Left Ventricular Assist Device	26
Angiographic Classification of Total Occlusion and Its Implication on Balloon Pulmonary Angioplasty	26
Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator	26
Prognostic Value of Left Atrial Reverse Remodelling in Patients Hospitalized with Acute Decompensated Heart Failure	26
Validation of Heart Failure Algorithm for Diagnosing Heart Failure with Preserved Ejection Fraction: A Meta-Analysis	26
Advances in Device-Based Treatment of Heart Failure with Preserved Ejection Fraction: Evidence from Clinical Trials	26
Bridging the post-hospitalization gap: a feasibility study of home-based rehabilitation in decompensated heart failure	26
Achieved Dose and Treatment Discontinuation of Candesartan in Men and Women with Chronic Heart Failure: Data from CHARM	25
Issue Information	25
Adrenomedullin Peptides and Precursor Levels in Relation to Haemodynamics and Prognosis After Heart Transplantation	25
Letter to the Editor Regarding ‘Autopsy Findings in Cases of Fatal COVID-19 Vaccine-Induced Myocarditis’	25
SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Adult Complicated by Myocarditis and Cardiogenic Shock	25
Lean ZSF1 Rats in Basic Research on Heart Failure with Preserved Ejection Fraction	24
Prognostic Value of Growth Differentiation Factors 15 in Acute Heart Failure Patients with Preserved Ejection Fraction	24
Identification of Molecular Signatures in Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction	23
Sex-Specific Associations of Cardiorespiratory Fitness and Galectin-3 in the General Population	23
Simultaneous Vaccination Against Influenza and Respiratory Syncytial Virus in High-Risk Heart Failure Patients	23

Rationale and Design of the Biventricular Evaluation of Gliflozins Effects In chroNic Heart Failure: BEGIN-HF Study	23
Time-Domain Heart Rate Variability Features for Automatic Congestive Heart Failure Prediction	23
Independent external validation of the LIFE-HF clinical prediction model using the GUIDE-IT trial	23
Letter to the Editor: Soluble Urokinase Plasminogen Activator Receptor and Outcomes in HFpEF: A TOPCAT Ancillary Study	23
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up	23
Congestion, Decongestion, Renal Function and Diuretics in (ESC) Heart Failure	23
Effects of Exercise Modalities on Physical Function and Quality of Life in Patients with Heart Failure: A Systematic Review and Network Meta-Analysis	23
A Prospective Analysis of Management and Outcomes of Worsening Heart Failure in the Outpatient Setting	23
Correction to “Understanding the Variability in Red Cell and Plasma Volume Combinations Can Help Guide Management in Heart Failure”	23
Reply on ‘High-urgency heart transplantation and outcome trade-offs: early post-transplant infection and mortality’	22
Dapagliflozin Reduces Pulmonary Vascular Damage and Susceptibility to Atrial Fibrillation in Right Heart Disease	22
Long-Term Mortality in Heart Failure with Mid-Range Ejection Fraction: Systematic Review and Meta-Analysis	22
Effects of Homoarginine Supplementation on Heart and Skeletal Muscle of Rats with Heart Failure with Preserved Ejection Fraction	22
The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study	22
Cost-Utility Analysis of Add-On Qili Qiangxin Capsules in Chronic Heart Failure with Reduced Ejection Fraction in China	22
Takotsubo Cardiomyopathy During Armed Conflict: A Case Series	22
Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study	22
Right ventricular to pulmonary artery coupling and clinical outcomes after interatrial shunting in heart failure: exploratory analysis of the PRELIEVE study	22
Left Ventricular Reverse Remodelling as a Promising Strategy for Resolving Left Ventricular Thrombus	22
Regional Expert Opinion: Management of Heart Failure with Preserved Ejection Fraction in the Middle East, North Africa and Turkey	22
Trimetazidine in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Cross-Over Trial	21
Acute Myocarditis According to Age: Presentation, Management and Early Outcomes	21
Incident Heart Failure: Comparing Management and Outcome in Primary and Hospital Settings in Western Sweden 2008–2017	21
Proteins Associated with Rehospitalization, Mortality and Diuretic Resistance in Acutely Decompensated Heart Failure	21
Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction	21
Clinical Impact of Follow-Up Endomyocardial Biopsy in Myocarditis During or After Immune-Suppressive Therapy	21
Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation	21
Gender-Specific Prevalence and Trend of Heart Failure in China from 1990 to 2019	20
Incidence, Mortality, and Predictors of Acute Kidney Injury in Patients with Heart Failure: A Systematic Review	20
Unaccounted immunosuppression and absent donor data limit infection risk after high-urgency heart transplantation	20
Diet–gut microbiota interaction Index and heart failure risk in diabetes and prediabetes: evidence from NHANES 2007–2018	20
Delay in Cardiology Consultation After Primary Care Physician Referrals in Heart Failure: Clinical Implications	20
Adaptive Versus Maladaptive Right Ventricular Remodelling	20
A Polygenic Risk Score of Atrial Fibrillation Improves Prediction of Lifetime Risk for Heart Failure	20
Letter to Dr Maria Giulia Bellicini, MD, Brescia, in response to her letter to the editor of our published paper in ESC Heart Failure (online); Worse long-term outcomes in new-onset HFpEF vs HFrEF and	20
Narrative Synthesis of the Effectiveness and Characteristics of Heart Failure Disease Self-Management Support Programmes	20
Importance of Non-Cardiovascular Comorbidities in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction	20
Human Epididymis Protein 4 is a Useful Predictor of Post-Operative Prognosis in Patients with Severe Aortic Stenosis	20
Real-World Effectiveness of Targeted Therapies in ATTR Cardiomyopathy: A Meta-Analysis Integrating Population-Based Data	20
High-urgency heart transplantation and outcome trade-offs: early post-transplant infection and mortality	20
Biomarker Prognostication Across Universal Definition of Heart Failure Stages	20
Body Mass Index, Frailty, and Outcomes in Heart Failure with Preserved Ejection Fraction	19
Novel Mutation Associated with Non-Compaction Ventricular Myocardium: A Case Report	19
Pre-Emptive Treatment of Heart Failure Exacerbations in Patients Managed with the HeartLogic™ Algorithm	19
A Meta-Analysis of the Relationship Between Glycaemic Variability and the Mortality of Patients with Heart Failure	19
Iron deficiency and iron supplementation in heart failure: a dynamic phenotype and a moving therapeutic target	19
Smartwatches in the Assessment of Heart Failure Patients in Epidemiology and Pathophysiology Studies: A Scoping Review	19
Sex-Based Differences in Referral of Heart Failure Patients to Outpatient Clinics: A Scoping Review	19
Letter Regarding the Article “Hypocapnia is an Independent Predictor of In-Hospital Mortality in Acute Heart Failure”	19
Long-Term Prognosis of Pure and Impure Tachycardiomyopathy	19
Plasma Volume Status Predicting Clinical Outcomes in Patients Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair	19
Clinical Application and Immune Infiltration Landscape of Stemness-Related Genes in Heart Failure	19
Cognitive Transitions Based on Functional Status in Older Adults with Heart Failure: A Population-Based Study	18
Analysis of the Usefulness and Benefits of Ultrafiltration in Cardiorenal Syndrome: A Systematic Review	18
Tyrosine to Threonine Ratio was Related to Heart Failure with Reduced or Mildly Reduced Ejection Fraction	18
Comments on ‘The cardio–pancreatic axis in heart failure: from conceptual framework to empirical evidence’	18
Efficacy and Safety of Digital Therapeutics-Based Cardiac Rehabilitation in Heart Failure Patients: A Systematic Review	18
The Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Patients Aged Over 80 Years with Heart Failure	18
Early Diagnosis, Disease Stage and Prognosis in Wild-Type Transthyretin Amyloid Cardiomyopathy: The DIAMOND Study	18
Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction	18
The Characteristic Large-Scale Annual Analysis by Gender and Age in Heart Failure Patients: Cohort for 10 Years in Korea	18
Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy	18
E Prostanoid Receptor-3 Promotes Oxidized Low-Density Lipoprotein-Induced Human Aortic Smooth Muscle Cells Inflammation	18
The Impact of Heart Failure Therapy in Patients with Mildly Reduced Ejection Fraction: A Network Meta-Analysis	18
A Contemporary Simple Risk Score for Prediction of Severe Acute Kidney Injury After Heart Transplantation	18
Temporal Profiling of M-TEER-Related Complications	18
Sodium portable tester for instantaneous natriuresis assessment: the SPOT-Na study	18
Effects of Door-to-Tolvaptan Time on Short-Term Clinical Outcome in Patients with Acute Heart Failure	18
Changes Over Time in Patient-Reported Outcomes in Patients with Heart Failure	18
Investigating the Relationship Between Frailty and Quality of Life in Patients with Heart Failure and CKD (FRAIL Study)	18
Interplay Between Acute Heart Failure and COPD in Patients Hospitalized for Dyspnea: Prognostic Insights From the PARADISE Cohort	18
Severe Aortic Insufficiency-Induced Cardiogenic Shock Treated with Left Atrial VA-ECMO and Emergent Valve-in-Valve TAVR	18
Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography	18
Considerations for Drug Trials in Hypertrophic Cardiomyopathy	18
Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry	18
Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis	17
General and disease-specific health literacy in patients with heart failure: an outcome analysis	17
Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study	17
Integrin Beta-Like 1 is Regulated by DNA Methylation and Increased in Heart Failure Patients	17
Cardiovascular vs. Non-Cardiovascular Deaths After Heart Failure Hospitalization in Young, Older, and Very Old Patients	17

Study design of the EDGEFIRM trial: transcatheter edge-to-edge repair versus guideline-directed medical therapy in atrial functional mitral regurgitation and HFpEF	17
Role of Vericiguat in Management of Patients with Heart Failure with Reduced Ejection Fraction After Worsening Episode	17
Clinical Performance and Quality Measures for Heart Failure Management in China: The China-Heart Failure Registry Study	17
Heart failure and cognitive impairment: a narrative review	17
Prognosis of tricuspid regurgitation after mitral transcatheter edge-to-edge repair: the EXPANDed studies	17
Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Centre Experience	17
Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study	17
Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis	17
Predicted Impact of Atrial Flow Regulator on Survival in Heart Failure with Reduced and Preserved Ejection Fraction	17
Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: For Which Patients?	17
Diuretic Dose is a Strong Prognostic Factor in Ambulatory Patients Awaiting Heart Transplantation	16
Therapy Gaps for Patients with Heart Failure and Reduced Kidney Function: A Prospective Cohort Study	16
Trametinib Alters Contractility of Paediatric Noonan Syndrome-Associated Hypertrophic Myocardial Tissue Slices	16
Global burden of heart failure due to cardiovascular diseases, 1990–2021 and predictions to 2035 based on GBD 2021	16
Correction to: “Obesity and Contraceptive Use: Impact on Cardiovascular Risk”	16
Estimated Pulse Wave Velocity and Risk of New-Onset Heart Failure	16
Sodium-Glucose Transporter 2 Inhibitors May Improve the Prognosis of Acute Heart Failure by Correcting Hypocapnia	16
Life-saving Balloon Aortic Valvuloplasty performed in a patient with cardiogenic shock	16
Use of soluble guanylyl cyclase stimulators in heart failure therapy—a mode of action perspective	16
Is Ischaemic Heart Failure an Autoimmune Disease?	16
S2I2N0–3 Score Predicts Short- and Long-Term Mortality and Morbidity in HFrEF: A Post-Hoc Analysis of the GUIDE-IT Trial	16
Issue Information	16
Paediatric Heart Transplantation During the COVID-19 Pandemic in Iran: Single-Centre Experience	16
Relationship Between Haemodynamic Indicators and Haemogram in Patients with Heart Failure	16
Issue Information	16
Baseline Kidney Function and the Effects of Dapagliflozin On Health Status in Heart Failure in DEFINE-HF and PRESERVED-HF	16
The prognostic value of RV strain in patients with heart failure with reduced ejection fraction on sacubitril/valsartan: a critical appraisal and future directions	16
Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies	16
Serum a-1 Antitrypsin as a Novel Biomarker in Chronic Heart Failure	16
Eniluracil Blocks AREG Signalling-Induced Pro-Inflammatory Fibroblasts of Melanoma in Heart Failure	16
A Nationwide Study of Temporal Trends of Cause-Specific Hospital Readmissions in Patients with Heart Failure	15
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)	15
Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure	15
Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients	15
Mavacamten in Real-Life Practice: Initial Experience at a Hypertrophic Cardiomyopathy Centre	15
Real-world data on early initiation of sodium-glucose co-transporter-2 inhibitors in newly diagnosed heart failure with reduced ejection fraction	15
Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes	15
Atrial-Secondary Tricuspid Regurgitation: A Better Prognosis in Early Stage Heart Failure, But Not in Late Stage	15
Systematic Review of Sodium-Glucose Cotransporter 2 Inhibitors: A Hopeful Prospect in Tackling Heart Failure-Related Events	15
Cardiac magnetic resonance imaging parameters predict new-onset symptoms of heart failure in hypertrophic cardiomyopathy	15
Association of Charlson Comorbidity Index with Clinical Characteristics and Outcomes in Heart Failure	15
Fractional Excretion of Urea Nitrogen Can Identify True Worsening Renal Function in Patients with Heart Failure	15
Multiorgan Characterization of Inflammasome Component Expression in a Rat Model of Advanced Heart Failure	15
Effects of Bariatric Surgery on Cardiovascular-Related Acute Care Use in Patients with Hypertrophic Cardiomyopathy	15
Impact of the COVID-19 Pandemic on Management and Outcomes of Patients with Acute Heart Failure	15
Low-Density Lipoprotein Cholesterol, Erythrocyte, and Platelet in Heart Failure with Preserved Ejection Fraction	15
Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation	15
Clinical Profile and 90 Day Outcomes of 10 851 Heart Failure Patients Across India: National Heart Failure Registry	15
Safety and Efficacy of MitraClip in Acutely Ill (NYHA Class IV) Patients with Mitral Regurgitation: Results from the Global EXPAND Study	15
Dramatic Disease Regression in a Case of HFrEF with End-Stage Renal Failure Treated with Sacubitril/Valsartan and SGLT2i	14
Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy	14
Ten Year Age- and Sex-Specific Temporal Trends in Incidence and Prevalence of Heart Failure in Västra Götaland, Sweden	14
Transition from Asymptomatic to Symptomatic Systolic Chronic Heart Failure: Rationale and Design of TransitionCHF	14
Decreased Endogenous Nitric Oxide Production in Acute Decompensated Heart Failure with a Reduced Ejection Fraction	14
Improved Mortality and Haemodynamics with Milrinone in Cardiogenic Shock Due to Acute Decompensated Heart Failure	14
A Case of Biopsy-Proven Inflammatory Dilated Cardiomyopathy Following Heterologous mRNA-1273 Third-Dose Immunization	14
In Vivo Fluid Dynamics of the Ventura Interatrial Shunt Device in Patients with Heart Failure	14
ST-Segment Depression and Left Ventricular Systolic Function Recovery Post-Atrial Fibrillation Ablation in Heart Failure	14
Congestion, decongestion, renal function, and diuretics in (ESC) heart failure—what’s new?	14
Short-Term Outcomes After Sodium-Glucose Cotransporter-2 Inhibitor Initiation in a Cohort of Heart Failure Patients	14
Prognostic Effect of Systematic Geriatric Assessment on Patients with Acute Heart Failure	14
Prognostic Impact of Beta-Blocker Use by N-Terminal Pro-Brain Natriuretic Peptide Level in Acute Heart Failure Patients	14
Association of Hypoxic Burden Metrics with Cardiovascular Outcomes in Heart Failure and Sleep-Disordered Breathing	14
U-Shaped Association Between Body Mass Index and Ejection Fraction in Intensive Care Unit Patients with Heart Failure	14
Predicting 1-Year Heart Failure Hospitalization and Mortality Post-Discharge from the Intensive Cardiac Care Unit	14
Comprehensive Exploration of Unexplained Dyspnoea in Subjects with Normal Ejection Fraction and Low Natriuretic Peptides	14
Association between cumulative exposure to cardiometabolic index and risk of heart failure: a prospective cohort study	14
Increased Calcification by Erythrophagocytosis in Aortic Valvular Interstitial Cells	14
Frailty Alone and Interactively with Obesity Predicts Heart Failure: Kuopio Ischaemic Heart Disease Risk Factor Study	14
Associations Between In-Hospital Daily Protein Intake and Adverse Clinical Outcomes in Older Patients with Heart Failure	14
Cardiac biomarkers response under angiotensin receptor–neprilysin inhibitor: a sub-analysis of the NATRIUM-HF study	14
The Favourable Alliance Between CardioMEMS and Levosimendan in Patients with Advanced Heart Failure	14
Correction to “Impact Analysis of Heart Failure Across European Countries: An ESC-HFA Position Paper” and “Echocardiographically Defined Haemodynamic Categorization Predicts Prognosis in Ambulatory He	14
Clinical Characteristics, Outcome, and Therapeutic Effect of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy	14
Multidisciplinary Care: A Missing Solution to SGLT2 Inhibitor Underuse in Heart Failure	14
Metformin inhibits proliferation of residing fibroadipogenic progenitor cells from failing human hearts	14
Pre-Admission Beta-Blocker Therapy and Outcomes in Cardiogenic Shock: Insights from the Altshock-2 Registry	14
Cardiac Arrest Caused by Coronary Occlusion During Transcatheter Aortic Valve Implantation: A Unique Cause	14
Application of Recommended Therapies Among Patients with Heart Failure During the Syrian Conflict: Reality and Barriers	14
Addressing the gaps in heart failure treatment for frail older adults: challenges, evidence, and future directions	14
Dapagliflozin Treatment and Cardiovascular Outcome in RBP4/TTRVal30Met (Transthyretin Cardiac Amyloidosis) Mice	14
Sex Differences in the Association Between Nutritional Status and in-Hospital Mortality in HFpEF Patients	13
Clinical Impacts of Sacubitril/Valsartan on Patients Eligible for Cardiac Resynchronization Therapy	13
A Year in Heart Failure: Updates of Clinical and Preclinical Findings	13
Aortic Thoracic Neuromodulation in Heart Failure with Preserved Ejection Fraction	13
Representativeness of the PIONEER-HF and PARAGLIDE-HF in Patients Hospitalized with Acute Heart Failure	13
Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo  31P magnetic resonance spe	13
Risk Prediction of Mortality for Patients with Heart Failure in England: Observational Study in Primary Care	13
Transjugular Tricuspid Valve-in-Ring Replacement Using the Novel System Under Three-Dimensional Printing Guidance	13
Apixaban in Bridge to Transplant and Destination LVAD - Rationale and Study Design: The ApixiVAD Trial	13
Prescribed Opioid Use is Associated with Adverse Cardiovascular Outcomes in Community-Dwelling Older Persons	13
Issue Information	13
Spontaneous Coronary Hematoma Concomitant with Myocarditis: The First Report of Double Cardiac Complication of Dengue	13
Prognostic Impact of Plasma Volume Status During Hospital Admission in Patients with Acute Decompensated Heart Failure	13
Systemic Blood Pressure in Severe Aortic Stenosis: Haemodynamic Correlates and Long-Term Prognostic Impact	13